Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma (LA HPSCC)

被引:0
|
作者
Zhang, Y. [1 ]
Gao, W. [1 ]
Feng, L. [1 ]
Zhao, X. [1 ]
Huang, Z. [1 ]
Chen, D. [1 ]
Yin, G. [1 ]
Guo, W. [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China
关键词
D O I
10.1016/j.annonc.2024.10.462
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
439P
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
    Yang, Peng
    Zhou, Xiao
    Yang, Xuefeng
    Wang, Yuefeng
    Sun, Tao
    Feng, Shiying
    Ma, Xianyou
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [42] The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma
    Chen, Yong
    Zhu, Shuangmei
    Lan, Xiang
    Hu, Tianzhen
    Ma, Lele
    Ye, Hong
    Wang, Baoqiang
    He, Xiao
    Wang, Hanying
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2024, 2024
  • [43] Clinical Efficacy of Taxol Plus Platinum (TP) Chemotherapy Combined with Delayed Administration of PD-1 Inhibitors in Patients with Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective Study
    Shen, Lin
    Chen, Zixuan
    Zhang, Zhi
    Wu, Yunjiang
    Ren, Yue
    Li, Ying
    Li, Yue
    Yin, Xudong
    Han, Fang
    Chen, Yong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2761 - 2773
  • [44] Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
    Cheng, Daoan
    Zhao, Weiqing
    Chen, Rui
    Li, Dong
    Tang, Shuxian
    Fang, Cheng
    Ji, Mei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [45] Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
    Daoan Cheng
    Weiqing Zhao
    Rui Chen
    Dong Li
    Shuxian Tang
    Cheng Fang
    Mei Ji
    World Journal of Surgical Oncology, 21
  • [46] Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study
    Lv, Chengliu
    Wu, Yahua
    Gu, Weiwei
    Du, Bin
    Yao, Na
    Zhu, Yingjiao
    Zheng, Jianping
    Hong, Yaping
    Lai, Jinhuo
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
    Feng, Yuan
    Sun, Wei
    Zhang, Jie
    Wang, Yang
    Chen, Jinfeng
    Liu, Xinying
    Wang, Liang
    Li, Shaolei
    Lv, Chao
    Lu, Fangliang
    Zhang, Jianzhi
    Hong, Yang
    Xiao, Shanshan
    Wang, Tao
    Jiao, Raymond
    Wang, Ziping
    Qi, Liping
    Li, Nan
    Yang, Yue
    Lin, Dongmei
    Fang, Jian
    THORACIC CANCER, 2022, 13 (03) : 442 - 452
  • [48] The efficacy and feasibility of neoadjuvant immunotherapy plus chemotherapy followed by McKeown minimally invasive oesophagectomy for locally advanced oesophageal squamous cell carcinoma
    Luo, Rao-Jun
    Li, Zhi-Jun
    He, Zheng-Fu
    Yan, Pei-Jian
    Wang, Yun-Zheng
    Xu, Shao-Hua
    Zhu, Zi-Yi
    JOURNAL OF MINIMAL ACCESS SURGERY, 2024, 20 (03) : 334 - 341
  • [49] Neoadjuvant chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Chung, Jooseop
    Cho, Goon Jae
    Shin, Ho Jin
    Choi, Young Jin
    Wang, Soo Geun
    Lee, Won Sik
    Joo, Young Don
    Sohn, Chang Hak
    Park, Kyung Tae
    ANNALS OF ONCOLOGY, 2006, 17 : 182 - 182
  • [50] Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer
    Zhu, Chengpei
    Xue, Jingnan
    Wang, Yunchao
    Wang, Shanshan
    Zhang, Nan
    Wang, Yanyu
    Zhang, Longhao
    Yang, Xu
    Long, Junyu
    Yang, Xiaobo
    Sang, Xinting
    Zhao, Haitao
    FRONTIERS IN IMMUNOLOGY, 2023, 14